Optison
Sponsors
St. Jude Children's Research Hospital, University Hospital, Basel, Switzerland, University of Nebraska, GE Healthcare, University of Michigan
Conditions
Abdominal NeoplasmsCarotid Artery DiseaseCarotid StenosisCoronary Artery DiseaseCoronary StenosisCrohn's DiseaseHeart TransplantationLymphedema Arm
Phase 1
Determination of a Safe Dose of Optison in Pediatric Patients With Solid Tumors
CompletedNCT00186953
Start: 2002-06-30End: 2004-08-31Updated: 2011-09-20
Assessing Myocardial Blood Flow and Blood Flow Reserve by Transoesophageal Echocardiography (TEE)
WithdrawnNCT00286559
Start: 2006-08-31End: 2008-12-31Updated: 2015-03-25
Contrast-Enhanced Ultrasound in Human Crohn's Disease
WithdrawnNCT02061163
Start: 2015-02-28End: 2018-01-31Updated: 2015-06-15
CeVUS With Intravesical Administration of OPTISON TM (Trademark) in Children
CompletedNCT02204917
Start: 2014-07-31End: 2017-03-31Updated: 2018-11-27
Contrast-Enhanced Ultrasound and Shear Wave Elastography for the Treatment of Lymphedema
CompletedNCT05613946
Start: 2022-12-15End: 2024-06-30Updated: 2024-08-21
Phase 2
Dose-Finding, Feasibility Study of Optison in Contrast Enhanced U/S for the Detection of Carotid Artery Disease
TerminatedNCT01394926
Start: 2011-06-30End: 2012-06-30Updated: 2014-05-02
Two and Three Dimensional Contrast-enhanced Ultrasound for Screening of Renal Cell Carcinoma Recurrence Following Cryoablation
CompletedNCT02440334
Start: 2015-04-23End: 2018-06-21Updated: 2025-05-04
Phase 4
IRB 14-009240, Does CEUS Positively Influence Selection of Biopsy Sites When Evaluating Transplant Kidneys?
CompletedNCT02625428
Start: 2015-11-30End: 2019-12-31Updated: 2020-03-02
Study to Determine Safety and Dosage of OPTISON in Pediatric Participants
CompletedNCT03740997
Start: 2020-12-01End: 2023-03-30Updated: 2024-05-17